Disorders of Hemostasis in Overt and Subclinical Hypercortisolism

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Experimental and clinical endocrinology & diabetes

• Publication date

  2013-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1055/s-0033-1355385PMID 24277483
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Thrombin generation in Cushing’s Syndrome: do the conventional clotting indices tell the whole truth?

  2014cited by this paper
• Hypercoagulability in Cushing's syndrome: prevalence, pathogenesis and treatment

  2013cited by this paper
• Homocysteine and alpha-1 antitrypsin concentration in patients with subclinical hypercortisolemia.

  2012cited by this paper
• Effect of glucocorticoids on von Willebrand factor levels and its correlation with von Willebrand factor gene promoter polymorphism

  2012cited by this paper
• Adipokines and Cardiovascular Risk in Cushing’s Syndrome

  2011cited by this paper
• The estimation of selected endogenous anticoagulation system parameters in patients with subclinical Cushing's syndrome.

  2011cited by this paper
• New Insight into the Hypercoagulability of Cushing’s Syndrome

  2011cited by this paper
• Diagnosis and Treatment of Subclinical Hypercortisolism

  2011cited by this paper
• Incidence of venous thromboembolism in patients with Cushing's syndrome: a multicenter cohort study.

  2011cited by this paper
• Changes in coagulation indexes and occurrence of venous thromboembolism in patients with Cushing's syndrome: results from a prospective study before and after surgery.

  2010cited by this paper
• The serum profile of adipokines in overweight patients with metabolic syndrome.

  2010cited by this paper
• Adipose tissue activity in relation to overweight or obesity.

  2010cited by this paper
• Hormones, haemostasis, and the risk of thrombosis

  2010cited by this paper
• Subclinical hypercortisolism: correlation between biochemical diagnostic criteria and clinical aspects

  2010cited by this paper
• Coagulopathy in Cushing’s Syndrome

  2010cited by this paper
• Homocysteine and arterial thrombosis: Challenge and opportunity

  2010cited by this paper
• Management of adrenal incidentaloma.

  2009cited by this paper
• [Hypercortisolism and hemostasis].

  2009cited by this paper
• Blood coagulation and fibrinolysis in patients with Cushing’s syndrome: Increased plasminogen activator inhibitor-1, decreased tissue factor pathway inhibitor, and unchanged thrombin-activatable fibrinolysis inhibitor levels

  2009cited by this paper
• Hypercoagulability in Cushing’s syndrome: the role of specific haemostatic and fibrinolytic markers

  2009cited by this paper
• Effect of high-dose dexamethasone on endothelial haemostatic gene expression and neutrophil adhesion.

  2009cited by this paper
• Adrenal incidentalomas and subclinical Cushing's syndrome: diagnosis and treatment

  2009cited by this paper
• Biochemical markers for cardiovascular risk following treatment in endogenous Cushing’s syndrome

  2008cited by this paper
• [Effect of selected hormones on particular parameters of hemostasis].

  2007cited by this paper
• Hyperhomocysteinemia and thrombosis: an overview.

  2007cited by this paper
• Effects of short-term glucocorticoids on hemostatic factors in healthy volunteers.

  2006cited by this paper
• Apolipoprotein B: a predictor of inflammatory status in postmenopausal overweight and obese women

  2006cited by this paper
• Clustering of insulin resistance with vascular dysfunction and low-grade inflammation in type 2 diabetes.

  2006cited by this paper
• High dose dexamethasone increases circulating P-selectin and von Willebrand factor levels in healthy men

  2005cited by this paper
• Sulfur amino acids in Cushing's disease: insight in homocysteine and taurine levels in patients with active and cured disease.

  2005cited by this paper
• Can we identify metabolically healthy but obese individuals (MHO)?

  2004cited by this paper
• Thrombophilia in Patients with Hypertriglyceridemia

  2004cited by this paper
• Effects of glucocorticoids on gene transcription.

  2004cited by this paper
• Hyperhomocysteinemia in patients with Cushing's syndrome.

  2004cited by this paper
• Associations of haemostatic variables with body mass index: a community-based study

  2003cited by this paper
• Plasminogen activator inhibitor‐1, inflammation, obesity, insulin resistance and vascular risk

  2003cited by this paper
• Coagulation and fibrinolysis abnormalities in obesity

  2002cited by this paper
• Inhibition of Platelet‐Collagen Interaction An In Vivo Action of Insulin Abolished by Insulin Resistance in Obesity

  2002cited by this paper
• Relationship between IL-6, leptin and adiponectin and variables of fibrinolysis in overweight and obese hypertensive patients.

  2002cited by this paper
• Insulin resistance syndrome: interaction with coagulation and fibrinolysis.

  2002cited by this paper
• Anticoagulant prophylaxis markedly reduces thromboembolic complications in Cushing's syndrome.

  2002cited by this paper
• [Changes in levels of acute phase proteins in patients with central hypercortisolism].

  2002cited by this paper
• Patients with subclinical Cushing's syndrome due to adrenal adenoma have increased cardiovascular risk.

  2002cited by this paper
• Factor VII, tissue factor pathway inhibitor, and monocyte tissue factor in diabetes mellitus: influence of type of diabetes, obesity index, and age.

  2001cited by this paper
• Taurine Prevents the Decrease in Expression and Secretion of Extracellular Superoxide Dismutase Induced by Homocysteine: Amelioration of Homocysteine-Induced Endoplasmic Reticulum Stress by Taurine

  2001cited by this paper
• Biochemical basis for the hypercoagulable state seen in Cushing syndrome; discussion 1006-7.

  2001cited by this paper
• Plasminogen activator inhibitor-1 and haemostasis in obesity

  2001cited by this paper
• Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance.

  2001cited by this paper
• Plasma Leptin and the Risk of Cardiovascular Disease in the West of Scotland Coronary Prevention Study (WOSCOPS)

  2001cited by this paper
• Leptin-dependent platelet aggregation and arterial thrombosis suggests a mechanism for atherothrombotic disease in obesity.

  2001cited by this paper
• Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features.

  2000cited by this paper
• Markers of activation of coagulation and fibrinolysis in patients with Cushing’s syndrome

  2000cited by this paper
• Hyperinsulinemia, hyperglycemia, and impaired hemostasis: the Framingham Offspring Study.

  2000cited by this paper
• C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women.

  2000cited by this paper
• Subclinical Cushing's syndrome.

  2000cited by this paper
• Abnormalities of von Willebrand factor are also part of the prothrombotic state of Cushing's syndrome.

  1999cited by this paper
• Glucocorticoids and insulin resistance: old hormones, new targets.

  1999cited by this paper
• Glucocorticoids and insulin promote plasminogen activator inhibitor 1 production by human adipose tissue.

  1999cited by this paper
• Measurement of cytokines in the cavernous sinus plasma from patients with Cushing's disease.

  1998cited by this paper
• Subclinical Cushing's syndrome in adrenal incidentaloma

  1998cited by this paper
• Increase in both pro-thrombotic and anti-thrombotic factors in obese premenopausal women: relationship with body fat distribution

  1997cited by this paper
• Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance.

  1996cited by this paper
• Hemostatic Effects of Stress Hormone Infusion

  1994cited by this paper
• Impact of weight loss on plasminogen activator inhibitor (PAI-1), factor VII, and other hemostatic factors in moderately overweight adults.

  1993cited by this paper
• Activated protein C: alpha 1-antitrypsin (APC: alpha 1 AT) complex as a marker for in vitro diagnosis of prethrombotic states.

  1992cited by this paper
• The fibrinolytic potential in patients with Cushing's disease: a clue to their hypercoagulable state

  1992cited by this paper
• Physiologic inhibition of human activated protein C by alpha 1-antitrypsin.

  1988cited by this paper
• Type 1 plasminogen activator inhibitor gene: functional analysis and glucocorticoid regulation of its promoter.

  1988cited by this paper
• Further Studies on the Hypercoagulable State of Patients with Cushing’s Syndrome

  1985cited by this paper
• THROMBOEMBOLIC COMPLICATIONS IN CUSHING'S SYNDROME

  1983cited by this paper
• Alpha-1-antitrypsin-human leukocyte elastase complexes in blood: quantification by an enzyme-linked differential antibody immunosorbent assay and comparison with alpha-2-plasmin inhibitor-plasmin complexes.

  1983cited by this paper
• Increased Factor VIII Associated Activities in Cushing's Syndrome: A Probable Hypercoagulable State

  1982cited by this paper
• [Disorders of hemostasis].

  1969cited by this paper
• The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 1999 by The Endocrine Society Hormonal Control of Plasminogen Activator Inhibitor-1 Gene Expression and Production in Human Adipose Tissue: Stimulation by Glucocorticoids and

  year unknowncited by this paper

• The Cortisol Effect on the NO/cGMP Pathway

  2025cites this paper
• Oxidative Stress Induced by Cortisol in Human Platelets

  2024cites this paper
• Pathophysiology of Mild Hypercortisolism: From the Bench to the Bedside

  2022cites this paper
• Hypercoagulability in Cushing's syndrome: From arterial to venous disease.

  2021cites this paper
• Approach to the Patient with Subclinical Cushing's Syndrome.

  2020cites this paper
• Psychotic, mood and anxiety disorders and venous thromboembolism: a systematic review and meta-analysis.

  2020cites this paper
• The role of selected adipokines in tumorigenesis and metabolic disorders in patients with adrenal tumors

  2020cites this paper
• Adrenal Incidentaloma: Picking out the High-Risk Patients

  2019cites this paper
• Adrenal Incidentaloma : Picking out the High-Risk Patients

  2019cites this paper
• Adrenal Incidentaloma : Picking out the High-Risk Patients

  2019cites this paper
• Adrenal Incidentaloma : Picking out the High-Risk Patients

  2019cites this paper
• Adrenal Incidentaloma: Picking out the High-Risk Patients

  2019cites this paper
• Adrenal Incidentaloma: Picking out the High-Risk Patients

  2019cites this paper
• Adrenal Incidentaloma : Picking out the High-Risk Patients

  2019cites this paper
• Adrenal Incidentaloma: Picking out the High-Risk Patients

  2019cites this paper
• Adrenal Incidentaloma : Picking out the High-Risk Patients

  2018cites this paper
• Adipokine and cytokine levels in non-functioning adrenal incidentalomas (NFAI).

  2018influential citation
• Adrenal Incidentaloma: Picking out the High-Risk Patients

  2018cites this paper
• Adrenal Incidentaloma : Picking out the High-Risk Patients

  2018cites this paper
• Adrenal Incidentaloma : Picking out the High-Risk Patients

  2018cites this paper
• Assessment of platelet function in endogenous hypercortisolism.

  2015cites this paper
• Cushing's syndrome due to ectopic ACTH secretion.

  2015cites this paper
• Hemostatic Disorders in Hormonally Active Pituitary Tumors

  2015cites this paper
• Activity of selected coagulation factors in overt and subclinical hypercortisolism.

  2015cites this paper